MAOLATE Drug Patent Profile
✉ Email this page to a colleague
When do Maolate patents expire, and what generic alternatives are available?
Maolate is a drug marketed by Pamlab Llc and is included in one NDA.
The generic ingredient in MAOLATE is chlorphenesin carbamate. There are two drug master file entries for this compound. Additional details are available on the chlorphenesin carbamate profile page.
Summary for MAOLATE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 49 |
Patent Applications: | 783 |
Formulation / Manufacturing: | see details |
DailyMed Link: | MAOLATE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for MAOLATE
US Patents and Regulatory Information for MAOLATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pamlab Llc | MAOLATE | chlorphenesin carbamate | TABLET;ORAL | 014217-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |